z-logo
open-access-imgOpen Access
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae
Author(s) -
Zaira R. PalaciosBaena,
Belén GutiérrezGutiérrez,
Marina de Cueto,
Pierluigi Viale,
Mario Venditti,
Alicia HernándezTorres,
Antonio Oliver,
Luis MartínezMartínez,
Esther Calbo,
Vicente Pintado,
Oriol Gasch,
Benito Almirante,
José Antonio Lepe,
Johann Pitout,
Murat Akova,
Carmen Peña-Miralles,
Mitchell J. Schwaber,
Mario Tumbarello,
Evelina Tacconelli,
Julia Origüen,
Núria Prim,
Germán Bou,
Helen Giamarellou,
Joaquín Bermejo,
Axel Hamprecht,
Federico Pérez,
Manuel Almela,
Warren Lowman,
PoRen Hsueh,
Carolivarro-San Francisco,
Julián TorreCisneros,
Yehuda Carmeli,
Robert A. Bonomo,
David L. Paterson,
Álvaro Pascual,
Jesús RodríguezBaño
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw513
Subject(s) - medicine , logistic regression , receiver operating characteristic , retrospective cohort study , cohort , septic shock , sepsis , bacteremia , cohort study , microbiology and biotechnology , biology , antibiotics
Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a predictive risk score for 30 day mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom